Harrow, Inc. (HROW)
35.13
-0.18
(-0.51%)
USD |
NASDAQ |
Apr 06, 16:00
35.14
+0.01
(+0.03%)
After-Hours: 20:00
Harrow SG&A Expense (TTM) : 152.91M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Esperion Therapeutics, Inc. | 165.79M |
| Corcept Therapeutics, Inc. | 448.72M |
| Regeneron Pharmaceuticals, Inc. | 2.70B |
| Theravance Biopharma, Inc. | 78.40M |
| Rhythm Pharmaceuticals, Inc. | 194.94M |